Hengan International Surges as UBS Raises Price Target to $34.90

Hengan International Group Co Ltd has delivered stronger-than-expected results for the second half of 2025. The Chinese hygiene products leader saw its stock price climb after UBS raised its price target to $34.90. Investors are taking note as the company maintains steady growth despite broader economic challenges.

The company's latest financial performance surpassed analyst forecasts. Revenue remained stable, while profit margins improved through tight cost management and adjusted pricing strategies. This resilience comes as China's hygiene sector expands, driven by urbanisation and higher living standards.

Hengan International's shares, listed on the Hong Kong Stock Exchange under ISIN HK1044000044, have seen a clear upward trend. On 17 March 2026, the stock rose from around €3.00 to €3.024 (+1.07%) following UBS's upgrade. The next day, it reached €3.146 (+1.19%), and by recent trading, it hit €3.216 (+4.42%).

The surge reflects growing confidence in the company's ability to navigate inflation and geopolitical tensions. Its focus on sustainable product innovation has also strengthened its position in Asia's fast-growing hygiene market.

For DACH investors, Hengan International offers an appealing way to gain exposure to China's consumer sector without currency risk. The stock's performance stands out amid broader market volatility, reinforcing its reputation as a stable long-term bet.

Hengan International's recent gains highlight its robust market position and investor appeal. With sustained demand and strategic cost controls, the company continues to outperform expectations. Analysts now view its shares as a key diversification opportunity in Asia's expanding hygiene industry.